ArticleOncotarget2018

Splice variants of the endonucleases XPF and XPG contain residual DNA repair capabilities and could be a valuable tool for personalized medicine.

Janin Lehmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.